The modeled difference between groups ( solanezumab group minus placebo group ) in the change from baseline was -@ points for the ADAS-cog@ score ( @ % confidence interval -LSB- CI -RSB- , -@ to @ ; P = @ ) and -@ points for the ADCS-ADL score ( @ % CI , -@ to @ ; P = @ ) in EXPEDITION @ and -@ points ( @ % CI , -@ to @ ; P = @ ) and @ points ( @ % CI , -@ to @ ; P = @ ) , respectively , in EXPEDITION @ .